Synonym
PD334581; PD 334581; PD-334581
IUPAC/Chemical Name
5-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)-N-(2-morpholinoethyl)-1,3,4-oxadiazol-2-amine
InChi Key
LZZYEMSEMRUPIM-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H19F3IN5O2/c21-14-3-2-13(18(17(14)23)26-16-4-1-12(24)11-15(16)22)19-27-28-20(31-19)25-5-6-29-7-9-30-10-8-29/h1-4,11,26H,5-10H2,(H,25,28)
SMILES Code
FC1=C(NC2=CC=C(I)C=C2F)C(C3=NN=C(NCCN4CCOCC4)O3)=CC=C1F
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
545.31
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
Spicer, J. A. (2008). New small-molecule inhibitors of mitogen-activated protein kinase kinase. Expert Opinion on Drug Discovery, 3(7), 801-817.
Wu, P. K., & Park, J. I. (2015, December). MEK1/2 inhibitors: molecular activity and resistance mechanisms. In Seminars in oncology (Vol. 42, No. 6, pp. 849-862). WB Saunders.
Wang, Y., Zhang, H., Cui, J., Zhang, J., Yin, F., Guo, H., ... & Xing, B. (2019). Opiate-associated contextual memory formation and retrieval are differentially modulated by dopamine D1 and D2 signaling in hippocampal–prefrontal connectivity. Neuropsychopharmacology, 44(2), 334-343.
